Meridian Diagnostics receives all-clear from FDA:
This article was originally published in Clinica
Executive Summary
Meridian Diagnostics has received 510(k)clearance from the FDA for two of its enzyme immunoassays Premier Giardia and Premier Cryptosporidium. The tests can detect the presence of the waterborne parasites Giardia and Cryptosporidium in under two hours from a simple stool specimen, according to the Cincinnati-based company. Giardia, which is transmitted through improperly treated water, infects more than two million people in the US every year and Cryptosporidium is particularly harmful in patients with immuno-compromised conditions such as AIDS. The worldwide market for testing of these parasites is estimated at $20 million annually.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.